in Newswire January 13, 2022

Class Action Claims Walgreens’ Lidocaine Products Misrepresented as ‘Maximum Strength’

Dang v. Walgreens Co.

Filed: January 11, 2022 § 1:22-cv-00177

A lawsuit claims Walgreens falsely advertised its lidocaine products as “maximum strength” even though competing products contain a higher dose of the medication.

Last Updated on January 13, 2022 — 4:26 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.